|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Amortization of right-of-use assets | |||||
| Amortization of intangible assets | |||||
| Deferred income tax (benefit) expense | |||||
| Provision for credit losses | |||||
| Provision (credit) for credit losses | |||||
| Gains on disposal of fixed assets | |||||
| Depreciation and amortization of fixed assets | |||||
| Amortization of premiums on securities, net | |||||
| Gains on sales of loans held for sale, net | |||||
| Proceeds from sales of loans held for sale | |||||
| Loans originated and held for sale | |||||
| (Gains) losses on sale of other real estate owned, net | |||||
| Write-downs on other real estate owned | |||||
| Change in fair value of equity investments, net | |||||
| Net purchases of equity investments | |||||
| Losses on securities transactions, net | |||||
| Purchases of equity investments, net | |||||
| Amortization of deferred costs on subordinated debt | |||||
| Losses (gains) on interest rate swaps, net | |||||
| Income from bank owned life insurance | |||||
| Decrease (increase) in accrued interest receivable | |||||
| Decrease (increase) in other assets | |||||
| Increase (decrease) in accrued interest payable | |||||
| Increase (decrease) in other liabilities | |||||
| Payments on operating leases | |||||
| Expense related to restricted stock units for directors' deferred compensation plan | |||||
| Expense related to employee restricted stock awards | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Proceeds from sales of securities available for sale | |||||
| Proceeds from sales, maturities, calls, and principal paydowns on securities available for sale | |||||
| Proceeds from sales, maturities and principal collected on securities held to maturity | |||||
| Purchases of securities available for sale | |||||
| Purchases of securities held to maturity | |||||
| Purchase of FHLBNY and FRBNY stock | |||||
| Redemption of FHLBNY and FRBNY stock | |||||
| Proceeds from sales of fixed assets | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sale of other real estate owned | |||||
| Net (increase) in loans | |||||
| Net cash (used in) provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Net increase (decrease) in demand, interest-bearing demand, savings, and insured money market deposits | |||||
| Net increase (decrease) in time deposits | |||||
| Net change in FHLBNY overnight advances | |||||
| Principal payments made on capital leases | |||||
| Net increase (decrease) in FHLBNY overnight advances | |||||
| Increases in (payments on) finance leases | |||||
| Payment of subordinated debt issuance costs | |||||
| Purchase of treasury stock | |||||
| Sale of treasury stock | |||||
| Cash dividends paid | |||||
| Net cash (used in) provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| Income Taxes | |||||
| Supplemental disclosure of non-cash activity: | |||||
| Transfer of portfolio loans to loans held for sale | |||||
| Transfer of loans to other real estate owned | |||||
| Distribution of treasury stock for directors' compensation | |||||
| Dividends declared, not yet paid | |||||
| Transfer of fixed assets held for sale | |||||
| Right-of-use assets obtained through finance lease liabilities | |||||
| Right-of-use assets obtained through operating leases liabilities | |||||
Loading...